Belluscura to distribute X-PLOR in Singapore
By HME News Staff
Updated 10:07 AM CST, Wed December 13, 2023
LONDON and PLANO, Texas – Belluscura has received approval from the Singapore Health Sciences Authority to distribute its X-PLOR portable oxygen concentrator under its exclusive licensing with InnoMax Medical Device Technology Ltd. Belluscura partnered with InnoMax in August. "We are very excited to receive this approval, enabling us to launch sales in Singapore, as a first market in the (Association of Southeast Asian Nations) region,” said CEO Bob Rauker. “With our arrangement with InnoMax in place, we are confident that we can now deliver on the significant potential for our products in this large and growing region." According to Belluscura, approximately 5.9% of adults in Singapore above 40 have chronic obstructive pulmonary disease. The company received approval in September to distribute the X-PLOR in Hong Kong.
Comments